TrialCancer science2013

Phase I/II study of bortezomib-melphalan-prednisolone for previously untreated Japanese patients with multiple myeloma.

Yoshiaki Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.